• 2025-2027 - Assessment of neurodegeneration, ageing and cellular senescence in the brain of two mouse models of Down syndrome after long term exposure to cannabinoid receptor allosteric inhibition. 
    • Funding: 2416_GRT-2024B The Jérôme Lejeune Foundation (France).
  • 2024-2025 - DisSynAS. Deciphering synaptic alternative splicing in intellectual disability: from models to human.
    • Funding: Programa conjunt Fundació Centre de Regulació Genòmica-Universitat Pompeu Fabra en Genòmica Mèdica Evolutiva (Spain). 
  • 2023-2024 - Validation of transcriptional biomarkers for therapeutic improvement in intellectual disability using extracellular vesicles. 
    • Funding: 202224-30-31 Fundació La Marató de TV3 (Spain).
  • 2022-2025 - Interaction of the endocannabinoid system with vagal afferents in the context of cognitive enhancement and its assessment on aging models. 
    • Funding: PID2021-123482OB-I00 Ministerio de Economía y Competitividad-MINECO (Spain).